CollPlant Announces Proposed Name Change to OptiPhi Computing Reflecting Expansion to Computing with Light
Key Highlights
- ➤Proposed name change to OptiPhi Computing awaits shareholder approval November 24, 2026
- ➤Proposed Nasdaq ticker change from CLGN to OPHI awaits Nasdaq confirmation
- ➤LightSolver acquisition drives CollPlant’s expanded focus on photonic computing
- ➤LightSolver is developing a Laser Processing Unit using interacting lasers for computation
Expert Statements
Eran Rotem, CEO and CFO of CollPlant
“The transition to OptiPhi Computing marks a pivotal milestone in our corporate evolution, aligning our identity with the immense, high-growth opportunities we see in photonic computing”
Eran Rotem, CEO and CFO of CollPlant
“This new name perfectly captures our expanded strategic vision and our commitment to driving long-term shareholder value through next-generation deep tech.”
Dr. Ruti Ben Shlomi, Co-Founder and CEO of LightSolver
“We believe the future of computing will be built on light. OptiPhi reflects our ambition to pioneer a fundamentally new computing architecture, where photons do more than carry information — they compute”
Dr. Ruti Ben Shlomi, Co-Founder and CEO of LightSolver
“This is an important step in establishing photonic computing as a core part of the company’s identity while we continue advancing the LPU toward commercialization.”
Rehovot, Israel, Nov. 04, 2026 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its Board of Directors has approved a proposal to change the Company’s name to OptiPhi Computing Ltd., subject to shareholders approval and completion of the applicable corporate and regulatory procedures. The proposed name reflects the Company’s focus on computing with light following its acquisition of LightSolver Ltd. (“LightSolver”) in September 2026.
The Company intends to submit the proposed name change for approval at an upcoming general meeting of shareholders, scheduled for November 24, 2026. In connection with the proposed change, the Company also intends to change its Nasdaq trading symbol from “CLGN” to “OPHI”, subject to Nasdaq confirmation and completion of the applicable process. Until the changes become effective, the Company will continue to operate under the CollPlant Biotechnologies Ltd. name and trade on Nasdaq under “CLGN”. The Company plans to announce the effective date of the changes separately.
Get started
Create a free account to read the full story.